2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.
This grant will help the Historic New Harmony program establish the Historic New Harmony Religious Liberty Initiative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback